{"name":"Innocoll","slug":"innocoll","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1972-01-01","label":"Bupivacaine Hydrochloride And Epinephrine first approved","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2041-01-22","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2042-03-17","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2043-02-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2043-02-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2044-07-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Method of Use)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2044-07-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2044-07-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"},{"date":"2044-07-02","label":"Bupivacaine Hydrochloride And Epinephrine patent expiry (Formulation)","drug":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"XaraColl","genericName":"XaraColl","slug":"xaracoll","indication":"Hemostasis and infection prevention in surgical wounds","status":"marketed"},{"name":"Levofloxacin only","genericName":"Levofloxacin only","slug":"levofloxacin-only","indication":"Community-acquired pneumonia","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Bupivacaine HCl collagen-matrix implant","genericName":"Bupivacaine HCl collagen-matrix implant","slug":"bupivacaine-hcl-collagen-matrix-implant","indication":"Postoperative pain management following surgical procedures","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Bupivacaine HCl infiltration","genericName":"Bupivacaine HCl infiltration","slug":"bupivacaine-hcl-infiltration","indication":"Local infiltration anesthesia for surgical procedures","status":"phase_3"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"BUPIVACAINE","slug":"bupivacaine","indication":"Anesthesia for cesarean section","status":"marketed"}]}],"pipeline":[{"name":"XaraColl","genericName":"XaraColl","slug":"xaracoll","phase":"marketed","mechanism":"XaraColl is a bioabsorbable collagen matrix that delivers chlorhexidine locally to promote hemostasis and reduce infection in surgical wounds.","indications":["Hemostasis and infection prevention in surgical wounds","Use as an adjunct to hemostasis during general, cardiac, and vascular surgery"],"catalyst":""},{"name":"Bupivacaine HCl collagen-matrix implant","genericName":"Bupivacaine HCl collagen-matrix implant","slug":"bupivacaine-hcl-collagen-matrix-implant","phase":"phase_3","mechanism":"Bupivacaine HCl is released from a collagen matrix implant to provide local anesthesia at the surgical site.","indications":["Postoperative pain management following surgical procedures"],"catalyst":""},{"name":"Bupivacaine HCl infiltration","genericName":"Bupivacaine HCl infiltration","slug":"bupivacaine-hcl-infiltration","phase":"phase_3","mechanism":"Bupivacaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.","indications":["Local infiltration anesthesia for surgical procedures"],"catalyst":""},{"name":"Bupivacaine Hydrochloride And Epinephrine","genericName":"BUPIVACAINE","slug":"bupivacaine","phase":"marketed","mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain.","indications":["Anesthesia for cesarean section","Itching of skin","Local Anesthesia for Ophthalmologic Procedure","Local anesthesia","Local anesthetic intrathecal block"],"catalyst":""},{"name":"Levofloxacin only","genericName":"Levofloxacin only","slug":"levofloxacin-only","phase":"phase_2","mechanism":"Inhibits DNA gyrase and topoisomerase IV","indications":["Community-acquired pneumonia","Skin and skin structure infections","Complicated urinary tract infections"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQVXNYM1U3aHliRk1oal9OQklGbWpmTUw0NHZzdlFYMDVaMXpnMXFndlV0U1JNQjdKNlMyOE91SHF6OFdrNW5RbFpTNHVfTVFNbzhPdzdwdkRHNW5VbXZEeENOVnpvamhQY3F4YlJReDU4blo4U0FmV3FfR0hMbzBLbG13MkZuT3AwVTl2MGNTONIBlAFBVV95cUxPbGJoYjJWa21iRWFHTHhsMmhaYVVTcUxsNGFJbVFIQnZ4Wl9yTnlLVnhFSW5PWU9La1RuOGVCNTMzZ2Y1RllvdjJGNE5nZU93Nnl4M194R3JVck91WTM3aUx2eFdEV19KWWFaTDVVV2FGWnVhQXlxd2NScmNYeXc0WnR5a0lRTC02YzBtSTExRzdjM0ho?oc=5","date":"2024-03-14","type":"pipeline","source":"Consulting.us","summary":"Lou Pascarella joins Beghou Consulting as advisor - Consulting.us","headline":"Lou Pascarella joins Beghou Consulting as advisor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWWU3cTFUam9GT3hnYU5henE0cTRvWDYxVGh0LWhCaFI2TzhRZXFQemNMSVBoVUdvTFFyZVotOUxSWVJnaXhSaGxRbW5BeHJackM0Y0lNazRSeU5GOGljN2h0ZDZ1WkpYVnBJUUVCN2ZPMGY3eldmYU9Ra1RCY1dvS0dNMHhrbE8tT0tKSlFmdEZmOVhXVEJRUzhkTVNTZC1MOUs2b0VJMEJHSDIzY0lnb0RDRERiMXFxVndoUlRteUMwZk1yUU5V?oc=5","date":"2023-01-26","type":"pipeline","source":"Business Wire","summary":"Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer - Business Wire","headline":"Innocoll Holdings Ltd. Appoints Kimball Hall as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9Rb085U0U1TjFYenFhU1Z1Z244RVdESDUwM29LRXN4cElaTU5wTlRNaEliZnhDWE9TMDBDWi1CWVpoTTk0d0E2aEVzcUcxY19kMi1qX0NNXzk?oc=5","date":"2022-05-02","type":"pipeline","source":"PharmaLive","summary":"NaviSync: 2022 - PharmaLive","headline":"NaviSync: 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOcDFHRWtTNDRKSXdVbnFXX0FvMEExdHlBUnVLVVVocThKcDBuSmZZcWNrUHNzb0dTZGZPM0lXMVRybXN3bjJHZTN3dDd4dUlic1RyWk9MckZwMHB0RDlVXzBMWFR4QzdYNzV0a0V6SElCUzNOSU53cldzY0p5Yno4UVJ2SzA5WmFmSXZsY193?oc=5","date":"2021-02-04","type":"pipeline","source":"BioSpace","summary":"Anthony Galdi Appointed Chief Commercial Officer of Innocoll - BioSpace","headline":"Anthony Galdi Appointed Chief Commercial Officer of Innocoll","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gJBVV95cUxNVXZ3ZDc4OGdoUzJnSWVqSzEwRVRDRVJOUWRmUzg4Rm00ek1ZcllDSV9ZRHVldnlkb1VHay1lX0dTVmJkb0syem43V00yR0R1MlA5QjA2SGZ1dHMtNTBiT21UNFhKNDJwQnNFeWJNYUtDQUw5Yml0S0tKZ3Q1M09fUUZuaUdMdW1leUw2Y181NDd2UFdwZTV1dVFIRHpRMXVTRGVReURVaURXQlhieWZ2RlUyRklXT0lxUWZNeUd6YXExWW44REtfLXRJa1JTREJwMEY3YUc4MmNLVS1vamN4U3JFeXR0Y3ZyUEVvSGZuQ0xtTVhNRWppLXpBcGFvY2ZWS01JMUdBRmoyNVhjdnlZZ3Y5WjlpSWZtNHE5MEl4OUxMSGxSSmdCN2Z1SlpaWXFCdVhIZ0VrM3dnVlpkM2E0SlVPWG4ybGZRZDFpSTNVdksxVXp5S3BDU182aVdnZw?oc=5","date":"2020-10-29","type":"pipeline","source":"BioSpace","summary":"Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI) implant, a Non-opioid, Drug-device Treatment Option for Acute Postsurgical Pain Relief for up to 24 Hours Following Open Inguinal He","headline":"Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI) implant, a Non-opioid, Drug-device Treatment Option ","sentiment":"neutral"},{"date":"2017-07-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"}],"patents":[{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11452691","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11819575","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11033495","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12144890","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11179336","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11426348","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12296047","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11357727","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11311486","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11278494","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11304904","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11819574","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11925706","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12151024","type":"Formulation","expiryDate":"2041-01-22","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11931459","type":"Method of Use","expiryDate":"2042-03-17","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12226610","type":"Method of Use","expiryDate":"2043-02-02","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"11918565","type":"Method of Use","expiryDate":"2043-02-02","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12318483","type":"Method of Use","expiryDate":"2044-07-02","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12370142","type":"Formulation","expiryDate":"2044-07-02","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12251468","type":"Formulation","expiryDate":"2044-07-02","territory":"US","genericFilings":[]},{"drugName":"Bupivacaine Hydrochloride And Epinephrine","drugSlug":"bupivacaine","patentNumber":"12156940","type":"Formulation","expiryDate":"2044-07-02","territory":"US","genericFilings":[]}],"drugCount":5,"phaseCounts":{"marketed":2,"phase_3":2,"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":null,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":null,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}